Physician profile
Nicolas Perez
NPI 1508124991
$1,456.23
in general payments reported to CMS, 2019-2025
19 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $48.06 · 2021: $202 · 2022: $287 · 2023: $249 · 2024: $223 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $387.17 | 2022-2025 | General - Pain Management, Intracept |
| Nevro Corp. | $225.29 | 2019-2024 | Senza |
| Painteq LLC | $182.88 | 2021-2023 | Painteq |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Almatica Pharma LLC | $91.20 | 2022-2023 | Gralise, Loreev Xr, Sertraline Hcl |
| Spr Therapeutics, INC | $89.84 | 2023-2024 | Sprint Pns System |
| Si-Bone, INC. | $61.41 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $60.14 | 2022-2023 | Seglentis |
| Abbott Laboratories | $41.87 | 2022-2024 | Proclaim |
| Abbvie INC. | $38.41 | 2022-2023 | |
| Saluda Medical Americas, INC. | $35.93 | 2025 | Evoke |
| Pfizer INC. | $29.06 | 2019-2021 | |
| Pacira Therapeutics, INC. | $24.49 | 2020 | |
| Vertos Medical, INC. | $20.65 | 2023 | Mild Device Kit |
| Lilly USA, LLC | $18.34 | 2023 | Reyvow, Emgality |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $16.27 | 2021 | |
| Sunovion Pharmaceuticals INC. | $12.70 | 2019 | |
| Allergan, INC. | $12.31 | 2019 | |
| Stimwave Technologies Incorporated | $10.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.